TESTOSTERONE HAS A suppressive effect on immune responses of vertebrates (for reviews, see refs [1] [2] [3] [4] and increases susceptibility toward numerous infectious diseases (for reviews, see refs 5, 6 ). In the experimental malaria Plasmodium chabaudi, for example, the suppressive effect of testosterone manifests itself as a host conversion from resistance to susceptibility: normally self-healing infections result in a fatal outcome (7, 8) . Concomitantly, testosterone induces a change in T cells from a resistance-promoting phenotype to a susceptibility-mediating phenotype, thus enabling the T cells to mediate the suppressive effect of testosterone (9) . Other circumstantial evidence also suggests direct testosterone effects on T cells (10, 11) . However, the mechanism of action of testosterone on T cells is not yet understood.
The currently prevailing view is that testosterone cannot directly act on T cells. This view is based on reports that T cells do not contain the classical androgen receptor (AR) 2 (for reviews, see refs 4, 5) . The AR is a protein of approximately 110 kDa with several domains for androgen binding, nuclear localization, dimerization, DNA binding, and transactivation (12, 13) . The predominant site of localization of AR in the absence of androgen is the cytoplasm, while ligand presence induces the import of AR into nuclei (12, 14) .
Recent findings have revealed unconventional nongenomic surface receptors for testosterone in rat osteoblasts (15) . These belong to the class of membrane receptors coupled to phospholipase C via a pertussis toxin-sensitive G-protein. Binding of testosterone to these cell surface receptors causes a rapid increase in intracellular free Ca 2/ concentration ([Ca 2/ ] i ) and an increased formation of inositol 1,4,5-triphosphate and diacylglycerol. Preliminary evidence indicates that in murine T cells, testosterone also induces a rapid rise in [Ca 2/ ] i , presumably due to Ca 2/ influx triggered by binding of testosterone to receptors on the outer surface of T cells (16) . However, it is also possible that testosterone diffuses through the plasma membrane, binds to intracellular AR, and secondarily induces the rise in [Ca 2/ ] i . To exclude this possibility, we have followed the effect of testosterone conjugated to bovine serum albumin (BSA), a conjugate that cannot cross the plasma membrane, on [Ca 2/ ] i of T cells. We have also reinvestigated the occurrence of classical AR in T cells.
MATERIALS AND METHODS

Mice
Specific pathogen-free mice of the strain C57BL/10 were obtained from the animal facility of our university. They received standard diet and water ad libitum.
Preparation of T cells
Spleens were aseptically removed from mice. Total nucleated spleen cells were isolated as detailed previously (9) . T cells were then prepared using the nylon-wool procedure (17) . This fraction contained 90-95% Thy 1.2 / T cells, as routinely examined in a FACScan (fluorescence-activated cell scanner; Becton Dickinson, Sunnyvale, Calif.). In some experiments, T cells were further purified; T cells were stained with anti-CD3-fluorescein isothiocyanate (FITC) (Pharmingen, Hamburg, Germany) and sorted in a FACScan according to standard procedures (18) . For cytosol preparation, T cells were isolated as Ig 0 cells by magnetic cell sorting (MACS) (19) . In brief, total spleen cells were labeled with biotin-conjugated anti-Ig monoclonal antibody (Boehringer, Mannheim, Germany), streptavidin-FITC, and biotinylated magnetic microparticles. The labeled cells were then separated by passage through a magnetized column obtaining the Ig 0 cells in the effluent. For localization of AR, the portion of cytoplasm was increased by stimulating T cells at 37ЊC, 5% CO 2 , and 98% humidity for 48 h with the monoclonal antibody anti-CD3e (5 mg/ml; Pharmingen, Hamburg, Germany) in RPMI 1640 medium supplemented with 5% fetal calf serum, 2 mM L-glutamine, 20 mM 2-mercaptoethanol, and 0.4% penicillin/streptomycin (5000 U/ml; 5000 mg/ml).
Determination of [Ca 2/ ] i
T cells were washed twice with 20 mM HEPES buffer (pH 7.2) supplemented with 130 mM NaCl, 5 mM KCl, 1 mM CaCl 2 , 0.5 mM MgCl 2 , 1 mM Na 2 HPO 4 and 1 mg/ml glucose. Subsequently, 10 7 T cells/ml were loaded with 3 mM Fura-2/acetoxymethylester (Amersham, Les Ulis, France) in the same buffer at 37ЊC for 20 min, diluted with 7 ml of HEPES buffer, and reincubated at 37ЊC for 20 min. The Ca 2/ measurements were performed in a Hitachi F-2000 spectrofluorometer at a constant temperature of 37ЊC. Reagents were added directly to the cuvette under continuous stirring. 
Visualization of androgen receptors
These experiments were performed with both intact and permeabilized T cells. The latter were fixed with 0.5% PFA in PBS / at 37ЊC for 30 min, then treated with 0.05% Tween-20, before diluting to 10 7 cells/ml in PBS / supplemented with 0.5% BSA and 0.05% Tween-20. Aliquots of 150 ml were centrifuged, and the cell pellets were incubated at room temperature for 1 h with 200 ml of the anti-AR antibody AR (N-20) (1 mg/ml; Santa Cruz Biotechnology, Heidelberg, Germany) or the anti-AR antibody AR (C-19) (0.5 mg/ml; Santa Cruz Biotechnology). Anti-rabbit immunoglobulin G (IgG) (whole molecule) FITC conjugate (working dilution 1:320; Sigma, Deisenhofen, Germany) was used as secondary antibody for 45 min. After two washings, the cells were resuspended in 0.5% PFA in PBS / and allowed to adhere onto polylysinecoated glass coverslips for 30 min. The coverslips were briefly rinsed with PBS / and mounted on slides as described above.
Confocal laser scanning microscopy
Cells labeled with testosterone-BSA-FITC and ConA-rhodamine were analyzed with a Leica confocal laser scanning microscope (CLSM) unit (Leica Lasertechnik, Heidelberg, Germany) mounted on a Zeiss IM 35 microscope (Zeiss, Oberkochen, Germany). FITC and rhodamine fluorescence were excited by the 488 nm argon laser line and the 568 nm krypton laser line, respectively. Z-series optical sections were taken at 0.5 mm intervals and evaluated using AVS software (Advanced Visual Systems Inc., Waltham, Mass.) on an Indigo 2 UNIX workstation (Silicon Graphics Inc., Mountain View,
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Calif.) as described elsewhere (21) . Cells labeled with the anti-AR antibodies AR (N-20) or AR (C-19) and FITC-labeled secondary antibody anti-rabbit IgG were analyzed with the CLSM LEICA TCS NT version 1.5.451 (Leica Lasertechnik, Heidelberg, Germany). FITC fluorescence was excited by the 488 nm argon laser line. Optical sections of 0.5 mm intervals were evaluated using Adobe Photoshop 5.0 for windows and CorelDraw 8 for windows.
Nuclear import of AR
Human prostate carcinoma LNCaP cells (DSM ACC 256; gift of Dr. Schultz, Urological Clinic, Heinrich-Heine-University, Duesseldorf, Germany) were cultured on polylysine-coated glass coverslips in RPMI 1640 medium supplemented with 10% fetal calf serum at 37ЊC and 5% CO 2 . LNCaP cells and intact T cells were incubated with 100 nM testosterone for 105 min at 37ЊC and 5% CO 2 before adding 100 nM testosterone again for 15 min. After two washings with PBS / , the cells were fixed with 0.5% PFA in PBS / at 37ЊC for 30 min and permeabilized with 0.05% Tween-20. These cells and corresponding control cells not preincubated with testosterone were monitored for AR as described above.
Flow cytometry
Intact and permeabilized T cells were labeled with testosterone-BSA-FITC, BSA-FITC, and the anti-AR antibodies AR (N-20) and AR (C-19), as described above. In some experiments, the reactions with the anti-AR antibodies were performed in the presence of 10-fold blocking peptides AR (N-20)P and AR (C-19)P, respectively (Santa Cruz Biotechnology, Heidelberg, Germany). Labeling with monoclonal antibody to mouse CD8 conjugated with phycoerythrin (CD8-PE, 1:500; Boehringer, Mannheim, Germany) and anti-mouse CD4-PE (1:200; Becton Dickinson, Heidelberg, Germany) was performed as described previously (9) . Cells were analyzed in a FACScan (Becton Dickinson) with a sample size of 10,000 cells gated on the basis of forward and side scatter. The data were stored and processed using the FACScan software as described previously (9).
Binding assay with 3 H-R1881
Cytosol was prepared from T cells isolated as Ig 0 cells according to standard procedures (22) . AR were measured using the dextran-coated charcoal method (23) , with slight modifications, and 3 H-R1881 (Amersham, Braunschweig, Germany) as a radioligand. As a control, parallel fractions were also assayed for glucocorticoid receptor using the dextran-coated charcoal technique method and 3 H-dexamethasone (Amersham) as a radioligand (22) .
Western blotting
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was carried out according to Laemmli (24) using 8% polyacrylamide gels with approximately 20 mg total protein per lane. The slab gels were positioned on nitrocellulose membranes (0.45 mm pore size, Schleicher & Schuell, Dassel, Germany), placed in a Biometra semi-dry blot cell (Biometra, Göt-tingen, Germany) between three sheets of Whatman paper (Whatman Ltd., Mainstone, U.K.) and soaked with transfer buffer (48 mM Tris, 39 mM glycerin, 0.0375% sodium dodecyl sulfate, 20% methanol). After blotting, the membranes were incubated with the anti-AR antibody AR (N-20) at a concentration of 0.1 mg/ml diluted in 10 mM Tris/HCl (pH 7.5), 0.15 mM NaCl, and 0.05% Tween (TST) at 23ЊC for 1 h, washed three times with TST for 10 min, and incubated at 23ЊC for 1 h with horseradish peroxidase-conjugated goat-antirabbit IgG (Santa Cruz Biotechnology, Heidelberg, Germany) diluted 1:50,000 in TST. After two washing steps, antibody detection was performed by the enhanced chemoluminescence plus Western blotting detection system (Amersham, Braunschweig, Germany) according to the manufacturer's instructions.
RNA isolation
Testes and spleens were taken from male C57BL/10 mice. The mouse macrophage cell line RAW 264.7 (ATCC number TIB-71) was cultivated in RPMI supplemented with 10% fetal calf serum. RNA was isolated from testes, spleens, RAW 264.7 cells, and FACSorted CD3 / T cells using the GTC/CsCl method (25) .
Reverse transcription-PCR
Polymerase chain reactions (PCR) were performed using the RNA-PCR Kit from Perkin-Elmer (Weiterstadt, Germany). For the initial random primed reverse transcription (RT), 1 mg of total RNA was used for each reaction in an MJ Minicycler (MJ Research, Biozym, Hess; Oldendorf, Germany). The PCR was carried out using AmpliTaq DNA Polymerase (Perkin-Elmer) and the oligonucleotide primer pair AR1 5-GACCTTGGATGGAGAACTACTCCG-3 and AR2 5-GGTTGGTTGTTGTCATGTCCGGC-3 for 32 cycles, with the following parameters: 94ЊC for 1 min, 56ЊC for 1 min, and 72ЊC for 1 min. PCR fragments were cloned into the pMOSBlue T vector (Amersham, Braunschweig, Germany).
DNA sequencing
Clones were analyzed by automated laser fluorescent sequencing using the LICOR sequencer (MWG, Ebersberg, Germany) with Thermo Sequenase fluorescent-labeled sequencing kit (Amersham, Braunschweig, Germany).
RESULTS
Testosterone binding sites on the T cell surface
The impeded ligand testosterone-BSA-FITC bound exclusively to the surface of intact T cells as revealed by CLSM (Fig. 1) . The fluorescence of testosterone-BSA-FITC colocalized with that of ConA-rhodamine, a marker of the plasma membrane (Fig. 1) . Binding of testosterone-BSA-FITC occurred on almost all intact T cells of both the CD4 / and CD8 / subset, as examined by flow cytometry (Fig. 2) . This binding was specific for testosterone, since BSA-FITC without conjugated testosterone did not adhere to T cells (Fig. 2) .
To test the possibility that the testosterone binding sites on the T cell surface were classical AR, intact T cells were incubated with the anti-AR antibody AR (N-20) and the anti-AR antibody AR (C-19). The AR (N-20) antibody is an affinity-purified rabbit polyclonal antibody raised against the amino acids 2-21 at the amino terminus of the AR, whereas the AR (C- 19) antibody is raised against a 20 amino acid peptide of the carboxy terminus of the AR. Neither anti-AR antibody revealed any significant fluorescence on T cells either by flow cytometry (Fig. 3, Fig. 4 ) or CLSM (data not shown). ] i of isolated splenic T cells by approximately 120-150 nM, whereas BSA alone had no effect on [Ca (Fig. 5) . This increase appeared as a prolonged elevation that was not due to saturation, since subsequent addition of 100 nM testosterone-BSA induced an additional increase in [Ca ] i of T cells (Fig. 5C) . Moreover, the Ca 2/ influx progressed through Ca 2/ channels, since the specific Ca 2/ channel blocker Ni 2/ inhibited the rise in [Ca 2/ ] i induced by testosterone-BSA (Fig. 5B) .
For characterization of the Ca 2/ channels, testosterone, instead of testosterone-BSA, was used to avoid any possible negative effects of the BSA component. Figure 6A shows that testosterone at the physiological concentrations of 1 and 10 nM was able to induce a 
Ca
2/ channel blocker Ni 2/ caused a gradual decrease and, at 5 mM Ni 2/ , an almost complete inhibition of the testosterone-induced Ca 2/ influx (Fig. 6C ). In the presence of Mn 2/ , which is known to bind avidly to Fura-2 and quench Fura-2 fluorescence, testosterone led to a decrease in fluorescence to well below the resting level (Fig. 6D) . In contrast, the voltage-gated channel blockers verapamil and nifedipine did not affect the testosterone-induced Ca 2/ channel-mediated Ca 2/ influx (Fig. 6E, F) .
Detection of classical AR
The presence of classical AR was examined in T cells, isolated as Ig 0 cells by MACS. These cells were fractionated and the cytosol was assayed for AR using 3 H-R1881 as a radioligand (0.39-200 nM final concentration) in the presence or absence of a 100-fold excess of nonlabeled hormone. In parallel fractions, the glucocorticoid receptor was measured using 3 Hdexamethasone as a radioligand. We were unable to detect any significant binding of 3 H-R1881 to the cytosol fraction. In parallel cytosolic fractions, however, Scatchard plot analysis revealed 1020 glucocorticoid receptor sites per T cell (K d Å2.22 nM), in accordance with previous findings (22, 26) .
In contrast, AR mRNAs were found in T cells. RNA was first extracted from FACSorted T cells containing more than 99% CD3 / cells. RT-PCR of this RNA using primers of the DNA binding domain of the AR revealed a band of the expected 486 nt size (Fig. 7A ). An identical band was detected in testes and spleens, but not in cells of the mouse macrophage cell line RAW 264.7 (Fig. 7A) . DNA sequencing confirmed that the PCR fragment from T cells contained the predicted region of the DNA binding domain.
Furthermore, Western blotting in combination with the very sensitive enhanced chemiluminescence detection system was used to identify AR in T cells and, comparatively, in the AR-expressing LNCaP cells (27) . The anti-AR antibody AR (N-20) reacted with the AR band at about 110 kDa in LNCaP cells (Fig. 7B) . The AR band was not visible when the antibody reaction was done in the presence of 10-fold blocking peptide AR (N-20)P (Fig. 7B) . The latter consists of the amino acids 2-21 of the amino terminus of the AR, the epitope recognized by the anti-AR antibody. In contrast to LNCaP cells, T cells contained only very low levels of AR protein. This became evident when the same amounts of T cell and LNCaP cell proteins were comparatively subjected to Western blotting at different exposure times. Figure 7C shows that a short expression time of 1 min detected the AR-band only in LNCaP cells. However, when the expression time of the same blot was increased to 10 min, a very faint band at 110 kDa could also be revealed in T cells (Fig. 7D) .
Moreover, AR could be structurally detected only in permeabilized T cells by using flow cytometry. corresponding fluorescent secondary antibody, fluorescence was observed in T cells (Figs. 3, 4) . This fluorescence was competitively displaced by the blocking peptides AR (N-20)P or AR (C-19)P, which exhibited the same amino acid sequence as the epitope recognized by the two anti-AR antibodies, respectively.
CLSM revealed that the anti-AR antibodies AR (N-20) and AR (C-19) labeled the cytoplasm of permeabilized T cells, whereas nuclei remained unlabeled (Fig. 8) . In these experiments, T cells were previously activated by anti-CD3e in order to increase the cytoplasmic portion. When intact T cells were preincubated with testosterone before permeabilizing with Tween-20 and labeling with the anti-AR antibody AR (N-20), the fluorescence was still located in the cytoplasm as in T cells without any testosterone preincubation (data not shown). Obviously, in the presence of testosterone, AR were not translocated into nuclei of T cells. By contrast, under the same incubation conditions, nuclear import of cytoplasmic AR was induced in more than 60% of human prostate carcinoma LNCaP cells (Fig. 9) .
DISCUSSION
This study provides experimental evidence for the presence of testosterone receptors on the surface of T cells. Binding sites for testosterone were localized on the plasma membrane of intact T cells using the ligand testosterone-BSA-FITC and CLSM. Testosterone conjugated to BSA, in contrast to testosterone, cannot cross the plasma membrane. Binding of testosterone-BSA-FITC occurred on almost all CD4 The membrane testosterone receptors apparently are also different from the membrane-associated estradiol (E 2 ) receptors recently identified in mouse T cells (28) . Indeed, binding of E 2 to E 2 receptors induces both an influx of Ca 2/ and a fast release of Ca 2/ from intracellular stores, whereas testosterone induces solely Ca 2/ influx. Moreover, the E 2 -induced Ca 2/ influx can be blocked by approximately 50% by nifedipine, whereas nifedipine has no effect on testosterone-induced Ca 2/ influx. Despite this difference, the presence of membrane receptors for both testosterone and E 2 in T cells support growing evidence indicating that plasma membranes of diverse other cells are associated with receptors for steroid hormones (29) (30) (31) , including androgens (32) (33) (34) (35) and estradiol (36, 37) . The nature and functioning of such membrane receptors are not yet understood. In prostate cell membranes, one possibility has been elaborated: membrane complexes consisting of sex hormone binding globulin (SHBG) bound to membrane SHBG receptor mediate rapid nongenomic effects of both androgens and E 2 , i.e., an increase in intracellular cAMP (38, 39) .
Moreover, we were surprised to also find classical intracellular AR in splenic T cells, even though the tally, a population of estrogen receptors has been reported that is cytoplasmic, but nontranslocatable to nuclei, in human breast cancer-derived MCF-7 cells (44) . The 'nontranslocatability' of AR in T cells strongly suggests that these AR are not active in the genomic pathway. The testosterone binding site at the carboxy terminus of the AR might possibly be inactivated, since specific binding of 3 H-R1881 in the cytosolic fraction of T cells cannot be detected. In this context, it is noteworthy that AR in T cells have been proposed to be developmentally regulated. Thus, immature T cells in the thymus possess functional AR (45, 46) . However, binding of testosterone is no longer observable in mature peripheral T cells, which have therefore been thought to contain no AR (45) , though this finding may also be explained by the presence of inactive AR, as reported here.
Finally, our data support earlier findings that cells contain testosterone receptors in their plasma membranes (15) . These membrane receptors do not mediate the classical genomic AR response, but rather suggest a novel nongenomic testosterone signaling pathway involving Ca 2/ as an intracellular mediator. However, the intracellular signaling varies between different cell types. In rat osteoblasts, for example, testosterone also induces Ca 2/ release from intracellular stores (15) , which is in contrast to what happens in T cells. However, the testosterone-induced nongenomic responses of intracellular Ca 2/ signaling could secondarily have 'genomic consequences'. Indeed, there is information available that Ca 2/ is able to modulate expression of specific genes in diverse cell types including T cells (47) , for example, through Ca 2/ -responsive promotor elements (CARE) and/or negative CARE and/or through Ca 2/ sensitive transcription factors such as NF-AT, NF-kB, and c-Jun amino-terminal kinase (48) .
